Panbela therapeutics, inc. to acquire cancer prevention pharmaceuticals, inc.

Minneapolis, feb. 22, 2022 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, today announced it has entered into a definitive agreement to acquire cancer prevention pharmaceuticals, inc. (“cpp”), a private clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases, for a combination of stock and future milestone payments.
PBLA Ratings Summary
PBLA Quant Ranking